Novocure Ltd. Forecast, price target & analysts
Novocure Ltd. Target price 2025 - Analyst rating & recommendation
Novocure Ltd. Classifications & Recommendation:
Novocure Ltd. Price Target
| Target Price | $35.57 |
| Price | $19.23 |
| Potential |
84.98%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Novocure Ltd. 2026 .
The average Novocure Ltd. target price is $35.57.
This is
84.98%
register free of charge
$42.00
118.41%
register free of charge
$29.00
50.81%
register free of charge
|
|
| A rating was issued by 7 analysts: 5 Analysts recommend Novocure Ltd. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Novocure Ltd. stock has an average upside potential 2026 of
84.98%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 509.34 | 605.20 |
| 5.30% | 18.82% | |
| EBITDA Margin | -42.25% | -1.73% |
| 190.24% | 95.91% | |
| Net Margin | -41.39% | -23.14% |
| 133.99% | 44.09% |
1 Analyst has issued a sales forecast Novocure Ltd. 2024 . The average Novocure Ltd. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Novocure Ltd. EBITDA forecast 2024. The average Novocure Ltd. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Novocure Ltd. Analysts have issued a net profit forecast 2024. The average Novocure Ltd. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.95 | -1.30 |
| 121.59% | 33.33% | |
| P/E | negative | |
| EV/Sales | 3.45 |
7 Analysts have issued a Novocure Ltd. forecast for earnings per share. The average Novocure Ltd. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Novocure Ltd. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current Novocure Ltd. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Jan 14 2025 |
| Piper Sandler | Locked ➜ Locked | Locked | Dec 13 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Dec 03 2024 |
| Evercore ISI Group | Locked ➜ Locked | Locked | Dec 02 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Dec 02 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Nov 21 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Oct 31 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Jan 14 2025 |
|
Locked
Piper Sandler: Locked ➜ Locked
|
Dec 13 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Dec 03 2024 |
|
Locked
Evercore ISI Group: Locked ➜ Locked
|
Dec 02 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Dec 02 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Nov 21 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Oct 31 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
